HALO
NASDAQ · Biotechnology
Halozyme Therapeutics Inc
$84.89
+1.30 (+1.56%)
Analyst Consensus
Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
-75.2% upside
Low Target
$15.29
Average Target
$21.02
High Target
$24.22
Current Price
$84.89
Current
$84.89
$84.89
Target
$21.02
$21.02
$15.29
$21.02 avg
$24.22
Scenario Analysis
Bear Case
$15.29
-82.0%
Low target
Base Case
$21.02
-75.2%
Avg target
Bull Case
$24.22
+-71.5%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$84.44
0.5% from high
52-Week Low
$58.53
+45.0% from low
50-Day SMA
$71.23
+19.2% vs SMA
200-Day SMA
$65.75
+29.1% vs SMA
RSI (14)
47.6
Neutral
Target vs 52W High
$21.02
-75.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +5.4% |
| AMGN | Hold | 43 | 49% | $190.87 | -52.7% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +179.1% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -9.5% |
| REGN | Buy | 38 | 71% | $76.80 | -90.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -42.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -46.0% |
| BIIB | Buy | 44 | 64% | $91.45 | -55.7% |